The President of the EU Commission is accused of corruption and procedural breaches concerning COVID-19 vaccine contracts, while a Belgian court is examining her immunity.
A court in Liège, Belgium, is scheduled to rule on January 6, 2025, on whether Ursula von der Leyen, the European Commission President, will retain legal immunity in a case involving allegations of corruption related to the procurement of
COVID-19
vaccines.
This decision follows a complaint by Belgian lobbyist Frederic Baldan, who has accused von der Leyen of corruption, destroying public documents, and violating procedures.
Case Background
The allegations against von der Leyen are based on claims that she engaged in secret negotiations with
Pfizer CEO Albert Bourla via SMS to secure a €35 billion contract for 1.8 billion
COVID-19
vaccine doses.
Baldan claims these negotiations circumvented EU member states and lacked transparency.
Von der Leyen has claimed that the SMS messages were "accidentally deleted," which the court might humorously consider believing...
The first hearing took place on May 17, 2024, where the court asserted its authority over the issue.
However, further proceedings were delayed due to an objection from the European Public Prosecutor’s Office (EPPO), which argued that von der Leyen's immunity as EU Commission President protects her from legal action.
Charges and Allegations
Von der Leyen faces charges of:
- Usurpation of functions and title: Allegedly bypassing established procurement protocols.
- Destruction of public documents: Claims of deleting SMS texts during critical
vaccine negotiations.
- High-level corruption: Allegations of secretive dealings with
Pfizer.
The EPPO, responsible for probing financial crimes within EU institutions, has backed von der Leyen’s immunity claim.
Critics, including Baldan, have questioned the EPPO's impartiality, alleging it is shielding von der Leyen instead of thoroughly investigating the corruption claims.
Frederic Baldan’s Role
Frederic Baldan, the complainant, has been central to the controversy known as "Pfizergate." In 2023, he filed a criminal complaint accusing von der Leyen of abusing her authority, destroying documents, and corruption concerning her role in the
vaccine negotiations.
Baldan asserts that these actions breached EU regulations and financially harmed public funds.
Next Steps
The Belgian court’s ruling on January 6 will decide if von der Leyen’s immunity is applicable in this case.
If the court rules against her immunity, the allegations may lead to formal legal proceedings against the European Commission President.
The outcome of this hearing will have significant implications for accountability and transparency within EU institutions.
The case highlights ongoing concerns over the
COVID-19
vaccine procurement process and its broader implications for governance and oversight within the EU.